6.84
Cns Pharmaceuticals Inc 주식(CNSP)의 최신 뉴스
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times
CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com India
How strong is CNS Pharmaceuticals Inc. stock revenue growthWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
How CNS Pharmaceuticals Inc. stock responds to policy changesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Can CNS Pharmaceuticals Inc. stock outperform in 2025 bull marketAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock gaining market shareJuly 2025 Review & AI Optimized Trade Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Trend analysis for CNS Pharmaceuticals Inc. this weekJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com
Will CNS Pharmaceuticals Inc. stock deliver better than expected guidance2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
Full technical analysis of CNS Pharmaceuticals Inc. stockJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Will CNS Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Why CNS Pharmaceuticals Inc. stock remains resilientMarket Growth Summary & Verified Entry Point Detection - newser.com
Will CNS Pharmaceuticals Inc. stock see PE expansion2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - TipRanks
CNS Pharmaceuticals (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study - Digital Journal
CNS Pharmaceuticals (CNSP) Advances Lead Product for Brain Cance - GuruFocus
CNSP Forecasts Adequate Funding to Sustain Operations into Late 2026 - GuruFocus
CNS Pharmaceuticals : Reports Third Quarter 2025 Financial Results and Provides Corporate Update - MarketScreener
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ACCESS Newswire
Can volume confirm reversal in CNS Pharmaceuticals Inc.2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
Will CNS Pharmaceuticals Inc. stock return to pre crisis levelsInsider Buying & Long Hold Capital Preservation Plans - newser.com
MSN Money - MSN
Will CNS Pharmaceuticals Inc. stock recover after recent drop2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Is CNS Pharmaceuticals Inc. stock dividend yield sustainableEarnings Trend Report & Weekly Return Optimization Alerts - newser.com
자본화:
|
볼륨(24시간):